Merck KGaA
Frankfurter Strasse 250
Darmstadt 64293
Germany
49 6151 72 0
https://www.emdgroup.com
版塊: Healthcare
行業: Drug Manufacturers - Specialty & Generic
全職員工: 62,908
高階主管
| 名稱 | 頭銜 | 支付 | 行使價 | 出生年份 |
|---|---|---|---|---|
| Ms. Belen Garijo Lopez M.D. | Chair of Executive Board & CEO | 6.62M | 無 | 1960 |
| Ms. Helene von Roeder | CFO & Member of Executive Board | 1.23M | 無 | 1970 |
| Dr. Kai Beckmann | CEO of Electronics & Member of the Executive Board | 4.85M | 無 | 1965 |
| Mr. Peter Guenter | CEO of Healthcare Business & Member of Executive Board | 5.58M | 無 | 1962 |
| Dr. Matthias J. Heinzel | CEO of Life Science Sector & Member of Executive Board | 5.22M | 無 | 1967 |
| Ms. Barbara Weiland | Chief Compliance Officer | 無 | 無 | 1974 |
| Mr. Dietmar Eidens | Head of the Global HR Business Partner Organization | 無 | 無 | 1958 |
| Mr. Frank Gotthardt | Head of Corporate & Government Relations - Europe | 無 | 無 | 無 |
| Mr. Marc Horn | Head of Life Science Controlling | 無 | 無 | 1975 |
| Dr. Michael Heckmeier | Head of the Display Materials Business Unit for Performance Materials | 無 | 無 | 1967 |
描述
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing and tools, as well as products that help test nutritional value and identify quality inconsistencies. Its Healthcare segment discovers, develops, manufacturers, and markets prescription drugs and biopharmaceuticals for the treatment of oncology, neurology and immunology, fertility, endocrinology, as well as cardiovascular, diabetes, thyroid disorders, and multiple sclerosis; general medicines; and injection device and disease monitoring software. The Electronics segment supplies materials for the semiconductor and display industries and surface design, such as delivery systems and services, as well as surface solutions, including cosmetics, effect pigments, and functional solutions. In addition, it has in-licensing agreement with Debiopharm International SA for developing and commercializing drug candidates for the treatment of head and neck cancer; Jiangsu Hengrui Pharmaceuticals Co. Ltd. for developing, manufacturing, and commercializing drug candidates for the treatment of metastatic colorectal cancer; and Abbisko Therapeutics Co. Ltd. for developing and commercializing of drug candidates for the treatment of tenosynovial giant cell tumor, as well as license and collaboration agreement with Merck KGaA to discover two targeted protein degraders against critical oncogenic proteins. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA operates as a subsidiary of E. Merck KGaA.
公司管治
截至 2024年5月1日 止，Merck KGaA 的 ISS 管治質素評分為 3。 Pillar 分數正在審核中：1；董事會：4；股東權利：10；現金賠償：2。
